Diet and Cancer
The truth about diet and cancer: Top dietitian Jane Clarke reveals what to eat (and what to avoid) to beat the disease. Read the article here.
Genetic test for BRCA1/2
BRCA1 and BRCA2 are human genes that produce tumor suppressor proteins. Men with harmful BRCA1 or BRCA2 mutations have a higher risk of prostate cancer. A Toronto Women’s College Hospital research study, The Screen Project, provides Canadians access to affordable population-based genetic testing for the BRCA gene mutation. Watch the video here.
‘Sniffing’ urine to detect prostate cancer could prevent unnecessary biopsies
Scientists report progress toward minimizing unnecessary biopsies: They have identified the molecules likely responsible for the scent of prostate cancer, which could be detected by chemically “sniffing” urine. Read the article here.
Updated Guideline on Brachytherapy in Prostate Cancer
The Cancer Care Ontario guideline on brachytherapy for patients with prostate cancer was updated to account for new evidence. Read the article here.
15-year metastasis-free survival in men on active surveillance in The Netherlands
According to new data reported at the annual meeting of the European Association of Urology in London, active surveillance of men diagnosed with low-risk prostate cancer was not associated with an elevated risk for metastatic disease at 15 years of follow-up. Read the article here.
Finding common ground on how “best” to treat localized prostate cancer, and what to tell patients
With the goals of working together more collaboratively and to provide higher quality information for patients at the time of decision-making, a prostate cancer community partnership consensus (PCPC) panel was formed among six partnering centers in the Greater Toronto Area. Read the article here.
Evidence of Exercise and Nutrition Trial dietary and physical activity modifications
There is increasing evidence that low levels of physical activity and diets low in fruit and vegetables and high in meat and dairy products are risk factors for prostate cancer disease progression. The Prostate cancer: Evidence of Exercise and Nutrition Trial (PrEvENT) aimed to assess a diet and physical activity intervention in men undergoing radical prostatectomy for localized prostate cancer. Read the article here.
Could antidepressants stop prostate cancer from spreading?
In almost all cases where prostate cancer spreads to other areas of the body, the disease spreads to the bone first. In a new study, researchers reveal the discovery of an enzyme that helps prostate cancer cells to invade bone. Furthermore, certain antidepressant medications may have the potential to block this enzyme. Read the article here.
FDA approves treatment for people who need the toilet while sleeping
The Food and Drug Administration has approved the first ever treatment for people who get up to urinate at night. Noctiva is a nasal spray, designed to be taken twice-daily, that increases absorption of liquid into the kidneys, slowing urine production. Read the article here.
Prostate Cancer Cells Hijack Blood Cholesterol and Fuel Its Growth
High levels of cholesterol in the blood are frequently linked with aggressive prostate cancer, and researchers at Duke Cancer Institute have learned how the cancer cells hijack cholesterol and fuel its growth. Read the article here.